Selective vulnerability in Huntington's disease: Preferential loss of cannabinoid receptors in lateral globus pallidus

A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes

1993 • 7,941 citations

Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor

1992 • 5,504 citations

The functional anatomy of basal ganglia disorders

1989 • 5,166 citations

Structure of a cannabinoid receptor and functional expression of the cloned cDNA

1990 • 4,933 citations

Neuropathological Classification of Huntingtonʼs Disease

1985 • 2,517 citations

Determination and characterization of a cannabinoid receptor in rat brain.

1988 • 2,339 citations

Cannabinoid receptor localization in brain.

1990 • 2,248 citations

Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study

1991 • 2,139 citations

Differential loss of striatal projection neurons in Huntington disease.

1988 • 976 citations

Selective Sparing of a Class of Striatal Neurons in Huntington's Disease

1985 • 767 citations

Neuronal localization of cannabinoid receptors in the basal ganglia of the rat

1991 • 515 citations

Huntington's disease : a disorder of families

1989 • 324 citations

Controlled clinical trial of cannabidiol in Huntington's disease

1991 • 309 citations

NEUROCHEMICAL ALTERATIONS IN HUNTINGTON'S CHOREA

1980 • 285 citations

Comparative distribution of dopamine D‐1 and D‐2 receptors in the basal ganglia of turtles, pigeons, rats, cats, and monkeys

1987 • 265 citations

Sparing of acetylcholinesterase-containing striatal neurons in Huntington's disease

1987 • 253 citations

Abnormalities of Striatal Projection Neurons andN-Methyl-D-Aspartate Receptors in Presymptomatic Huntington's Disease

1990 • 244 citations

Comparison of ibotenate and kainate neurotoxicity in rat brain: A histological study

1983 • 236 citations

Loss of cannabinoid receptors in the substantia nigra in huntington's disease

1993 • 227 citations

Clinical and neuropathologic assessment of severity in Huntington's disease

1988 • 213 citations

Tetrahydrocannabinol for tremor in multiple sclerosis

1983 • 169 citations

The diagnosis of Huntington's disease

1986 • 165 citations

Huntington's disease

1984 • 165 citations

Treatment of Human Spasticity with Δ⁹‐Tetrahydrocannabinol

1981 • 155 citations

Human striatal dopamine receptors are organized in compartments.

1986 • 120 citations

Convergence of subthalamic and striatal efferents at pallidal level in primates: an anterograde double-labeling study with biocytin and PHA-L

1992 • 117 citations

The striatopallidal projection displays a high degree of anatomical specificity in the primate

1992 • 110 citations

A comparison of neurological, metabolic, structural, and genetic evaluations in persons at risk for Huntington's disease

1990 • 110 citations

Excitatory amino acid binding sites in the caudate nucleus and frontal cortex of huntington's disease

1991 • 91 citations

Population Studies in Northern Sweden

1994 • 90 citations

Heterogeneous dopamine receptor changes in early and late Huntington's disease

1991 • 88 citations

Compartmentalization of excitatory amino acid receptors in human striatum.

1992 • 77 citations

Evidence of presymptomatic cognitive decline in Huntington's disease

1992 • 71 citations

Preproenkephalin messenger RNA—containing neurons in striatum of patients with symptomatic and presymptomatic huntington's disease: An in situ hybridization study

1991 • 68 citations

Heterogeneous distribution of dopamine D1 and D2 receptors in the human ventral striatum

1993 • 32 citations

Brain GABA Levels in Asymptomatic Huntington's Disease

1990 • 21 citations

Pallidal GABA and chorea in Huntington's disease

1990 • 12 citations